Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer’s disease: Quinolotacrine hybrids
Mehrdad Sadafi Kohnehshahri, Gholamabbas Chehardoli, Masoomeh Bahiraei, et al.
Molecular Diversity (2021) Vol. 26, Iss. 1, pp. 489-503
Closed Access | Times Cited: 20

Showing 20 citing articles:

Structural and vibrational characterization of di-hydrated hydrochloride tacrine combining DFT with SQMFF approach
Tom Sundius, Silvia Antonia Brandán
Heliyon (2023) Vol. 9, Iss. 10, pp. e20936-e20936
Open Access | Times Cited: 24
In silico and in vitro studies confirm Ondansetron as a novel acetylcholinesterase and butyrylcholinesterase inhibitor
Asma Gholami, Dariush Minai‐Tehrani, Leif A. Eriksson
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Development of novel melatonin-isatin hybrids as multifunctional agents for Alzheimer’s disease
Yingying Zhong, Jun-Ze Deng, Qin Wang, et al.
Molecular Diversity (2025)
Closed Access
Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation
Sunil Kumar, Amritha Manoharan, J Jayalakshmi, et al.
RSC Advances (2023) Vol. 13, Iss. 14, pp. 9513-9529
Open Access | Times Cited: 10
Novel Pyrano[3,2-c]quinoline-1,2,3-triazole Hybrids as Potential Anti-Diabetic Agents: In Vitro α-Glucosidase Inhibition, Kinetic, and Molecular Dynamics Simulation
Soheila Esmaili, Ahmad Ebadi, Ardeshir Khazaei, et al.
ACS Omega (2023) Vol. 8, Iss. 26, pp. 23412-23424
Open Access | Times Cited: 10
Synthesis and biological assessment of novel 4H-chromene-3-carbonitrile derivatives as tyrosinase inhibitors
Mohammad Reza Azimi, Zahra Najafi, Asrin Bahmani, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Ultrasound-assisted synthesis of kojic acid-1,2,3-triazole based dihydropyrano[3,2-b]pyran derivatives using Fe3O4@CQD@CuI as a novel nanomagnetic catalyst
Zahra Najafi, Soheila Esmaili, Behnam Khaleseh, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Fused 1,4‐Dihydropyridines and Their Corresponding Pyridines: Synthesis, Molecular Modeling and Cholinesterase Inhibition
Zahra Najafi, Meysam Alaei, Asrin Bahmani, et al.
ChemistrySelect (2023) Vol. 8, Iss. 19
Closed Access | Times Cited: 6
Design, Synthesis, and biological evaluation of pyrazolo-benzothiazole derivatives as a potential therapeutic agent for the treatment of Alzheimer’s disease
Harish Kumar, Anju Goyal, Navneet Kumar, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 11, pp. 1931-1947
Closed Access | Times Cited: 9
Synthesis and molecular modeling of new 2‐benzylidenethiobarbituric acid derivatives as potent tyrosinase inhibitors agents
Zahra Najafi, Adel Kamari‐aliabadi, Reyhaneh Sabourian, et al.
Journal of the Chinese Chemical Society (2022) Vol. 69, Iss. 4, pp. 692-702
Closed Access | Times Cited: 8
Metal-free synthesis of functionalized tacrine derivatives and their evaluation for acetyl/butyrylcholinesterase and α-glucosidase inhibition
Thangellapally Shirisha, Subir Majhi, K. Divakar, et al.
Organic & Biomolecular Chemistry (2023) Vol. 22, Iss. 4, pp. 790-804
Closed Access | Times Cited: 4
Carltonine-derived compounds for targeted butyrylcholinesterase inhibition
Filip Pidaný, Jana Křoustková, Jaroslav Jenčo, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1601-1625
Open Access | Times Cited: 1
6‐Methoxy‐1‐tetralone Derivatives Bearing an N‐Arylpyridinium Moiety as Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, and Molecular Docking Study
Gholamabbas Chehardoli, Pooriya Gholamhoseini, Ahmad Ebadi, et al.
ChemistrySelect (2022) Vol. 7, Iss. 27
Closed Access | Times Cited: 6
Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer’s Disease
Cem Yamalı, Şeyda Dönmez
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 7, pp. 869-880
Closed Access | Times Cited: 6
تخليق و تشخيص معقدات القصدير العضوية الثلاثية – تايروسين ودراسة تطبيقاتها كمؤكسدات بطريقتي DPPH CUPRAC
Rafid Ryyis Arraq, Angham G. Hadi
Baghdad Science Journal (2024) Vol. 21, Iss. 11, pp. 3398-3410
Open Access
Synthesis, Molecular Modeling, and Biological Evaluation of New N-(Benzo[d]thiazol-2-yl)-3-amino-but-2-enamide Derivatives as Cytotoxic Agents
Mohammadreza Mahdian, Ahmad Ebadi, Asrin Bahmani, et al.
Organic Preparations and Procedures International (2023) Vol. 56, Iss. 3, pp. 292-301
Closed Access | Times Cited: 1
Carltonine-Derived Compounds for Targeted Butyrylcholinesterase Inhibition
Filip Pidaný, Jana Křoustková, Jaroslav Jenčo, et al.
(2023)
Closed Access
Design, Synthesis, and biological evaluation of pyrazolo-benzothiazole derivatives as a potential therapeutic agent for the treatment of Alzheimer’s disease
Harish Kumar, Anju Goyal, Navneet Kumar, et al.
Research Square (Research Square) (2022)
Open Access
The anti-Alzheimer potential of some novel Tacrine-Coumarin Derivatives as a Cholinesterase inhibitor
Somdatta Yashwant Chaudhari, Shailaja B. Jadhav
International Journal of Health Sciences (2022), pp. 10910-10932
Open Access
In silico and in vitro Studies Confirm Ondansetron as a Novel Acetylcholinesterase and Butyrylcholinesterase Inhibitor
Asma Gholami, Dariush Minai‐Tehrani, Leif A. Eriksson
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top